Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.41 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4090218 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL9863328 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL7407539 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL7359556 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL5362357 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL7411952 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL7094911 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL19664310 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL3407439 | 0.93 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53CHRM5CHRM1 | |
| SCHEMBL1830509 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3978473-B1 | COMPOUND CONTAINING AN INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | BEIJING AN JIAN XI BIO MEDICAL TECH CO LTD (CN) | 2026-05-06 | — | — | EP | disclosed |
| CN-115461055-B | Prodrugs of neuroactive steroids | 腾盛博药生物科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-115461055-A | Prodrugs of neuroactive steroids | 腾盛博药生物科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| EP-3978473-A1 | COMPOUND CONTAINING AN INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | Beijing An Jian Xi Bio-Medical Technology Co., Ltd (CN) | 2022-04-06 | — | — | EP | disclosed |
| EP-3252039-B1 | COMPOUND CONTAINING INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | BEIJING AN JIAN XI BIO MEDICAL TECH CO LTD (CN) | 2021-11-03 | — | — | EP | disclosed |
| US-20180022700-A1 | COMPOUND CONTAINING INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | BEIJING AN JIAN XI BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) | 2018-01-25 | — | — | US | disclosed |
| EP-3252039-A1 | COMPOUND CONTAINING INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | Beijing An Jian Xi Bio-Medical Technology Co., Ltd (CN) | 2017-12-06 | — | — | EP | disclosed |
| EP-0272446-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1992-11-11 | — | — | EP | disclosed |
| EP-0145739-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1989-02-08 | — | — | EP | disclosed |
| EP-0274025-A2 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-07-13 | — | — | EP | disclosed |
| EP-0273169-A2 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-07-06 | — | — | EP | disclosed |
| EP-0272446-A1 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-06-29 | — | — | EP | disclosed |
| WO-1984004748-A2 | NOVEL ANTIVIRAL AGENTS | — | 1984-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180022700-A1 | COMPOUND CONTAINING INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | IDO1, TPH1, IDO2 | ALDH1A1 380/4885TSHR 262/4885TP53 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.